| Mrs Ariel Jesse Herron, CNM | |
|
388 W Center St, Manchester, CT 06040-4735 | |
| (860) 649-1120 | |
| Not Available |
| Full Name | Mrs Ariel Jesse Herron |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 7 Years |
| Location | 388 W Center St, Manchester, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316469448 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 000420 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
The Associated Press reports on the larger enrollment in states that are expanding their Medicaid programs. However, The New York Times points out that the snags on the marketplace websites may be holding up thousands of others who will be eligible for the state-federal program for low-income people.
An open label Phase 3 study conducted at Ann & Robert H. Lurie Children's Hospital of Chicago and other centers established that a combination of cystic fibrosis drugs lumacaftor and ivacaftor is safe and effective in children aged 2-5 years, whose disease is caused by two copies of F508del-CFTR gene mutation - the most common and severe form of cystic fibrosis.
Researchers estimate that 7.7 million children under the age of 5 will die this year, an indication that global child deaths "seem to have fallen faster than officials thought," according to a study, published online Monday in the Lancet, the Associated Press reports (Cheng, 5/23).
Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.
Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer - the most common subtype of ovarian cancer - after standard treatment with the chemotherapy drug carboplatin.
› Verified 8 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
The Associated Press reports on the larger enrollment in states that are expanding their Medicaid programs. However, The New York Times points out that the snags on the marketplace websites may be holding up thousands of others who will be eligible for the state-federal program for low-income people.
An open label Phase 3 study conducted at Ann & Robert H. Lurie Children's Hospital of Chicago and other centers established that a combination of cystic fibrosis drugs lumacaftor and ivacaftor is safe and effective in children aged 2-5 years, whose disease is caused by two copies of F508del-CFTR gene mutation - the most common and severe form of cystic fibrosis.
Researchers estimate that 7.7 million children under the age of 5 will die this year, an indication that global child deaths "seem to have fallen faster than officials thought," according to a study, published online Monday in the Lancet, the Associated Press reports (Cheng, 5/23).
Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.
Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer - the most common subtype of ovarian cancer - after standard treatment with the chemotherapy drug carboplatin.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ariel Jesse Herron, CNM 191 Stuart Dr, Southington, CT 06489-3965 Ph: (860) 302-0967 | Mrs Ariel Jesse Herron, CNM 388 W Center St, Manchester, CT 06040-4735 Ph: (860) 649-1120 |
News Archive
The Associated Press reports on the larger enrollment in states that are expanding their Medicaid programs. However, The New York Times points out that the snags on the marketplace websites may be holding up thousands of others who will be eligible for the state-federal program for low-income people.
An open label Phase 3 study conducted at Ann & Robert H. Lurie Children's Hospital of Chicago and other centers established that a combination of cystic fibrosis drugs lumacaftor and ivacaftor is safe and effective in children aged 2-5 years, whose disease is caused by two copies of F508del-CFTR gene mutation - the most common and severe form of cystic fibrosis.
Researchers estimate that 7.7 million children under the age of 5 will die this year, an indication that global child deaths "seem to have fallen faster than officials thought," according to a study, published online Monday in the Lancet, the Associated Press reports (Cheng, 5/23).
Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative diseases that are characterized by misfolded proteins, such as Alzheimer's, Parkinson's and Huntington's diseases.
Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer - the most common subtype of ovarian cancer - after standard treatment with the chemotherapy drug carboplatin.
› Verified 8 days ago
Mr. Russell S Medbery Jr., Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 360 Tolland Tpke, Suite 3b, Manchester, CT 06042 Phone: 860-646-1157 Fax: 860-646-9877 | |
Mrs. Laura Alsen Piscioneri, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 201 E Center St, Manchester, CT 06040 Phone: 860-649-6199 Fax: 860-643-2123 | |
Ms. Jennifer Ann Walters, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 388 W Center St, Manchester, CT 06040 Phone: 860-649-1120 Fax: 860-645-8541 | |
Maura Aaberg, C.N.M., W.H.N.P. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 394 W Center St, Manchester, CT 06040 Phone: 888-607-0046 | |
Maria Diana Avellino, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 388 West Center St, Manchester, CT 06040 Phone: 860-649-1120 Fax: 860-645-8541 | |
Suzanne Murphy Barton, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 192 E Center St, Manchester, CT 06040 Phone: 888-607-0046 Fax: 888-690-0088 |